NCT02152982
Clinical Trial Information
Trial Number: NCT02152982 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Astrocytoma, High Grade
Trial Title:
"A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation"
Study ID:
A071102
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®